Resultados de la búsqueda
Saturi G, De Frutos F, Sguazzotti M, Gonzalez-Lopez E, Nardi E, Domínguez F, Ponziani A, Cabrera E, Caponetti AG, Lozano S, Massa P, Cobo-Marcos M, Accietto A, Castro-Urda V, Giovannetti A, Toquero J, Gagliardi C, Gómez-Bueno M, Rios-Tamayo R, Biagini E, Segovia J, Galiè N, García-Pavía P, Longhi S. Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis. Heart (2024) 110:40-48
Yun S, Palladini G, Anderson LJ, Cariou E, Wang R, Angeli FS, Ebede B, Garcia-Pavia P. International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction. Amyloid (2024) 31:291-301
de Frutos F, Saturi G, Gonzalez-Lopez E, Sguazzotti M, Dominguez F, Ponziani A, Cabrera-Romero E, Caponetti AG, Lozano S, Massa P, Peiro-Aventin B, Accietto A, Mora-Ayestarán N, Giovannetti A, Castro-Urda V, Gagliardi C, Cobo-Marcos M, Rios-Tamayo R, Biagini E, Gomez-Bueno M, Galiè N, Segovia-Cubero J, Longhi S, Garcia-Pavia P. Incidence and predictors of sudden death in patients with cardiac amyloidosis. Amyloid (2024) 31:334-338
Link to the full text in Repisalud
Link to the full text in Repisalud
Coats CJ, Masri A, Nassif ME, Barriales-Villa R, Arad M, Cardim N, Choudhury L, Claggett B, Düngen HD, Garcia-Pavia P, Hagège AA, Januzzi JL, Lee MMY, Lewis GD, Ma CS, Maron MS, Miao ZM, Michels M, Olivotto I, Oreziak A, Owens AT, Spertus JA, Solomon SD, Tfelt-Hansen J, van Sinttruije M, Veselka J, Watkins H, Jacoby DL, German P, Heitner SB, Kupfer S, Lutz JD, Malik FI, Meng L, Wohltman A, Abraham TP; SEQUOIA‐HCM Investigators. Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM. J Am Heart Assoc (2024) 13:e035993
de Frutos F, Ochoa JP, Webster G, Jansen M, Remior P, Rasmussen TB, Sabater-Molina M, Barriales-Villa R, Girolami F, Cesar S, Fuentes-Cañamero ME, Alvarez García-Rovés R, Wahbi K, Limeres J, Kubanek M, Slieker MG, Sarquella-Brugada G, Abrams DJ, Dooijes D, Domínguez F, Garcia-Pavia P; European Genetic Cardiomyopathies Initiative Investigators. Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy. J Am Heart Assoc (2024) 13:e036208.
Masri A, Sherrid MV, Abraham TP, Choudhury L, Garcia-Pavia P, Kramer CM, Barriales-Villa R, Owens AT, Rader F, Nagueh SF, Olivotto I, Saberi S, Tower-Rader A, Wong TC, Coats CJ, Watkins H, Fifer MA, Solomon SD, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Meng L, Sohn RL, Wohltman A, Maron MS; REDWOOD-HCM Investigators. Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4. J Card Fail (2024) S1071-9164:00082-4
Link to the full text in Repisalud
Link to the full text in Repisalud
Garcia-Pavia P, Kristen AV, Drachman B, Carlsson M, Amass L, Angeli FS, Maurer MS; THAOS investigators. Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS). J Card Fail (2024) S1071-9164:00222-7
Link to the full text in Repisalud
Link to the full text in Repisalud
Maron MS, Abraham T, Coats CJ, Olivotto I, Lee MY, Arad M, Cardim N, Ma CS, Choudhury L, Düngen HD, Garcia-Pavia P, Hagege A, Lewis GD, Michels M, Oreziak A, Owens AT, Tfelt-Hansen J, Veselka J, Watkins HC, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Meng L, Wohltman A, Masri A Baseline Characteristics of Patients in SEQUOIA-HCM: APhase 3 Trial of Aficamten in Obstructive Hypertrophic Cardiomyopathy. J Card Fail (2024) 30:S3-S3
Maurer MS, Soman P, Hernandez A, Garcia-Pavia P, Signorovitch J, Wei LJ, Hanna M, Ruberg FL, Kittleson M, Kazi D, Dorbala S, Hsu K, Lousada I, Adigun R, Dunnmon P, Kelly J, Gillmore J; Amyloidosis Forum Meeting Panelists. Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings. ADV THER (2024) 41:2723-2742.
Gómez González C, Del Campo Cano I, Isabel Fernández-Avila A, Paz Suárez-Mier M, José Sagastizábal M, Álvarez García-Rovés R, Méndez Fernández I, Vilches S, Centeno Jiménez M, Siles Sánchez-Manjavacas A, Usano Carrasco A, Gonzalez-Vioque E, Pablo Ochoa J, Medrano C, González López E, García-Pavía P, Bermejo J, Angeles Espinosa Castro M. Sudden cardiac death triggered by minimal alcohol consumption in the context of novel PPA2 mutations in 2 unrelated families GENE (2024) 916:148437
Link to the full text in Repisalud
Link to the full text in Repisalud
